Skip to content
PIL Logo

Estraderm MX

Last Updated on eMC 11-Jul-2016 View document  | Merus Labs Luxco S.a.R.L. Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11-Jul-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 01-Apr-2016 and displayed until 11-Jul-2016

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 26-Feb-2015 and displayed until 01-Apr-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 15-Sep-2014 and displayed until 26-Feb-2015

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 08-Jul-2014 and displayed until 15-Sep-2014

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 15-May-2014 and displayed until 08-Jul-2014

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 13-Sep-2013 and displayed until 15-May-2014

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 20-Sep-2011 and displayed until 13-Sep-2013

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions

Updated on 21-Oct-2009 and displayed until 20-Sep-2011

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 23-Jan-2009 and displayed until 21-Oct-2009

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 08-Sep-2008 and displayed until 23-Jan-2009

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 02-Jul-2007 and displayed until 08-Sep-2008

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 22-Mar-2006 and displayed until 02-Jul-2007

Reasons for adding or updating:

  • Change to side-effects

Updated on 07-Mar-2003 and displayed until 22-Mar-2006

Reasons for adding or updating:

  • Update to PIL

Updated on 09-Nov-2001 and displayed until 07-Mar-2003

Reasons for adding or updating:

  • Update to PIL

Updated on 08-Oct-2001 and displayed until 09-Nov-2001

Reasons for adding or updating:

  • Update to PIL

Updated on 02-Jan-2001 and displayed until 08-Oct-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Merus Labs Luxco S.a.R.L.

Company image
Address

26-28, rue Edward Steichen, L-2540, Luxembourg

Fax

+352 2711 27200

Medical Information e-mail
Stock Availability

+31 621590553

Telephone

+352 2711 27044

Medical Information Direct Line

+352 2637 5878

Customer Care direct line

+31 621590553

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

estradiol hemihydrate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue